Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Emergent BioSolutions Inc. | 215,367 | reported | 05 Mar 2026 | tx 62+909,234−176,805 |
| SPRINT NEXTEL CORP | 125,163 | reported | 04 Aug 2008 | tx 10+233,535−8,691 |
| Compass Therapeutics, Inc. | 90,000 | reported | 02 Jan 2026 | tx 4+220,000 |
| NEXTEL COMMUNICATIONS INC | 6,000 | reported | 28 May 2004 | tx 23+56,568−59,646 |
| CORPORATE EXECUTIVE BOARD CO | 0 | reported | 05 Apr 2017 | tx 91+239,348−133,548 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2025 | EXERCISE | Emergent BioSolutions Inc. | 19,963 | 0.00 USD | deriv |
| 25 Feb 2026 | EXERCISE | Emergent BioSolutions Inc. | 20,321 | 0.00 USD | deriv |
| 05 Mar 2026 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 23,650 | 8.44 USD | |
| 03 Mar 2026 | GRANT_AWARD | Emergent BioSolutions Inc. | 72,856 | 0.00 USD | deriv |
| 01 Mar 2026 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 683 | 8.15 USD | |
| 06 Feb 2026 | OTHER | Emergent BioSolutions Inc. | 46,155 | 10.92 USD | |
| 06 Feb 2026 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 5,642 | 10.92 USD | |
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 15 Oct 2025 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 4,995 | 9.60 USD | |
| 08 Jun 2025 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 2,733 | 6.63 USD | |
| 06 Mar 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 146,888 | 0.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 178,546 | 0.00 USD | deriv |
| 12 Feb 2025 | OTHER | Emergent BioSolutions Inc. | 16,916 | 0.00 USD | |
| 01 Mar 2025 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 683 | 7.48 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 1,073 | 7.48 USD | |
| 11 Feb 2025 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 15 Oct 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 15,000 | 0.00 USD | |
| 08 Jun 2024 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 2,733 | 6.19 USD | |
| 13 Mar 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 125,000 | 0.00 USD | deriv |
| 29 Feb 2024 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 9,037 | 3.23 USD | |
| 01 Mar 2024 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 684 | 3.39 USD | |
| 21 Feb 2024 | OTHER | Emergent BioSolutions Inc. | 4,012 | 2.71 USD | |
| 23 Feb 2024 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 517 | 2.74 USD | |
| 09 Feb 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | Emergent BioSolutions Inc. | 49,231 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 15 Nov 2021.